STAT

Opinion: Pharma should take a tip from the chemical industry to stem the outrage over drug pricing

The pharma industry needs to double down on direct community engagement and be far more transparent about drug pricing.
Americans aren't happy about the cost of drugs. Here New York City activists protest the high price of EpiPens. Source: Photo by Drew Angerer/Getty Images

No one seems to know what President Trump will say when (or if — he has postponed before) he addresses the nation this week on drug pricing. But the content doesn’t matter nearly as much as the implications. The mere fact that drug pricing has become such a populist issue that this president is devoting a policy speech to it will almost certainly roil markets and raise the collective blood pressure of pharmaceutical company CEOs.

When it comes to drug prices, an increasingly vocal majority of Americans now, for example, showed that only 13 percent of patients thought pharma companies effectively explain pricing policies.

You're reading a preview, sign up to read more.

More from STAT

STAT1 min readPsychology
Acadia Pharma Drug Fails To Improve Psychosis In Schizophrenia Patients
A plan to expand the use of Acadia Pharmaceuticals’ only approved medicine to cover the treatment of patients with schizophrenia was dealt a setback with the failure of a late-stage…
STAT5 min readSociety
What The Ebola Emergency Means, What It Doesn’t Mean, And What’s Next
Finally, the WHO has declared the world’s latest Ebola outbreak a global health emergency. But what, exactly, does that mean?
STAT7 min readScience
Do Elon Musk’s Brain-decoding Implants Have Potential? Experts Say They Just Might
Do Elon Musk’s brain-decoding implants have potential? Independent experts consulted by STAT say they very well might.